VERIFIED EFFICACY

• Has been shown to provide an immune response to West Nile virus that is four times more than a big one-shot combination vaccine.2
• WEST NILE-INNOVATOR vaccine was shown to be 96.7% effective against a 2003 outbreak among immunologically naïve horses.4
• The only vaccine credited for helping reduce the number of equine West Nile virus cases by nearly 70% from 2002 to 2003.7

ADVANCED SCIENCE

• The only West Nile virus vaccine adjuvanted with MetaStim for improved immune response.
• Helps stimulate fast, antigen-specific cell-mediated and humoral responses against West Nile virus.5,6
• Four combinations of WEST NILE-INNOVATOR allow a tailored fit for any vaccination program.
• Ready to use; no reconstitution required.

• Inject 1-mL dose intramuscularly to healthy horses 10 months of age or older using aseptic technique. Administer a second 1-mL dose three to six weeks after the first dose in unvaccinated or naïve horses.
• A 1-mL revaccination should be given annually in previously vaccinated horses.
• Always read and follow label indications.
• Early revaccination may be advisable when horses are faced with an outbreak or with other conditions that might make exposure likely.

CAUTIONS
Store in the dark at 2° to 7° C (35° to 45° F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. Thimerosal, neomycin and polymyxin B are added as preservatives.